Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/20967
Title: Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply.
Authors: Grigg, Sam E;Sarri, Gino L;Gow, Paul J;Yeomans, Neville D
Affiliation: University of Melbourne, Parkville, Vic, Australia
Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Jul-2019
Citation: Alimentary pharmacology & therapeutics 2019; 50(1): 117-120
URI: http://ahro.austin.org.au/austinjspui/handle/1/20967
DOI: 10.1111/apt.15324
ORCID: 0000-0002-6116-6595
0000-0001-9870-832X
PubMed URL: 31184392
Type: Letter
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.